Showing results (91-100 of 170) with videos related to
Sort By:
Pageof 17
Hypertension (Dallas, Tex. : 1979)|September 1, 1990
Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effectsM Richards, E Espiner, C Frampton, et al.Hypertension (Dallas, Tex. : 1979)|July 1, 1983
Mechanisms in human renovascular hypertensionA H Maslowski, M G Nicholls, E A Espiner, et al.Japanese Heart Journal|July 1, 1990
Relationship between plasma atrial natriuretic peptide concentration and atrial pressure in acute and chronic heart failureM Nakamura, N Arakawa, Y Abe, et al.British Heart Journal|August 1, 1987
Atrial natriuretic peptide in spontaneous tachycardiasI G Crozier, H Ikram, M G Nicholls, et al.British Heart Journal|December 1, 1982
Haemodynamic and hormonal effects of captopril in primary pulmonary hypertensionH Ikram, A H Maslowski, M G Nicholls, et al.The American Journal of Cardiology|September 15, 1985
Effect of enalapril on ventricular arrhythmias in congestive heart failureM W Webster, M A Fitzpatrick, M G Nicholls, et al.Lancet (London, England)|October 31, 1981
Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failureA H Maslowski, M G Nicholls, H Ikram, et al.Lancet (London, England)|November 17, 1984
Syncope in aortic valvular stenosisA M Richards, M G Nicholls, H Ikram, et al.Clinical and Experimental Pharmacology & Physiology|May 1, 1989
Atrial natriuretic peptide levels in congestive heart failure in man before and during converting enzyme inhibitionI G Crozier, M G Nicholls, H Ikram, et al.Journal of Hypertension|October 1, 1991
Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effectsA M Richards, G Wittert, E A Espiner, et al.Pageof 17